top of page

Program for Analytics and Compliance Education


Now is the time for regenerative medicine clinics, related medical service providers, and industry to comply with current regulations concerning Human Cells, Tissues and Cellular and Tissue-based Products (HCT/Ps). 

Across the United States, targeted enforcement of federal regulatory standards for the field of regenerative medicine has intensified. 

The US FDA, state authorities, professional licensing bodies, and other oversight agencies are all involved. Tech giants are now using their powerful search algorithms to identify  language used to promote the  stem cell  industry, and they too have tightened their own rules relating to the marketing tools used by those who practice regenerative medicine. 


Figure 1. Aggregate Target


Figure 1. Aggregate Target

Regenerative Outcomes’ PACE program helps clinics, practitioners, and industry navigate regulatory requirements and enforcement by highlighting potential non-compliant marketing practices intended for the public.


Regenerative Outcomes developed PACE using heuristic models inspired by companies and regulatory bodies like the FDA, Google, the Federation of State Medical Boards, International Society for Stem Cell Research, AARP and more. 


Take action now by contacting Regenerative Outcomes to learn how the PACE program can help your company or practice improve its compliance posture with Federal and other authorities.


The call you make today could help determine the future of your vital and life-changing work, and reduce an enforcement risk that could dilute both your potential - and  your bottom line.

bottom of page